European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

European Clinical Research Alliance on Infectious Diseases (ECRAID) - Business Plan

Descrizione del progetto

Rafforzare la battaglia contro le malattie infettive

Nonostante i progressi compiuti nel controllo e nella prevenzione delle malattie, quelle infettive rimangono una delle principali minacce per la salute e le economie globali. La riduzione dell’impatto esercitato dalle loro forme emergenti e dalla resistenza antimicrobica richiede un impegno di lungo termine, sostenibile e internazionale. I consorzi europei COMBACTE e PREPARE hanno l’ambizione congiunta di istituire un’infrastruttura coordinata, permanente e paneuropea per la ricerca clinica sulle malattie infettive (ECRAID). L’obiettivo di ECRAID sarà quello di ridurre l’impatto delle malattie infettive sulla salute individuale e della popolazione, generando prove rigorose per migliorarne la diagnosi, la prevenzione e il trattamento, nonché la risposta alle minacce che presentano. Il progetto ECRAID-Plan, finanziato dall’UE, agevolerà questo sforzo congiunto attraverso lo sviluppo di un piano commerciale dettagliato per ECRAID.

Obiettivo

Infectious diseases (ID) pose a continuous and serious threat to global health and economies. Reducing the impact of emerging infectious diseases (EID) and antimicrobial resistance (AMR) requires long-term, sustainable, international efforts. The European consortia COMBACTE and PREPARE have the joint ambition to establish a coordinated, permanent, pan-European infrastructure for clinical research on ID (ECRAID). The mission of ECRAID is to reduce the impact of ID on individual and population health by generating rigorous evidence to improve the diagnosis, prevention and treatment of IDs, and to better respond to ID threats. In ECRAID-Plan the coordinators and co-coordinators of PREPARE and COMBACTE, together with the (co-)coordinators of 12 other highly complementary networks and infrastructures, will develop a detailed Business Plan for ECRAID, which will serve: (i) as the guiding document in the implementation of ECRAID, (ii) to inform external stakeholders (network partners, industry, funders, policy makers, regulators, users) about ECRAID and (iii) to get commitment for sufficient start-up funding to commence operations in ECRAID, allowing for a smooth transition of activities from the current funding periods of PREPARE and COMBACTE. ECRAID-Plan will be completed within 24 months, involving extensive consultation of a multisectoral stakeholder platform. ECRAID-Plan will focus on the development of the key components of the business plan, including (i) an internal analysis of strengths and weaknesses, (ii) an external analysis of relevant stakeholders and their needs, developments in the scientific, policy and other domains and opportunities and threats, (iii) the service offering and business model, (iv) operational processes and policies, (v) governance structure and (vi) an investment plan and operational budget. Cross-cutting themes include reconciliation of AMR and EID research, data sharing and interoperabilty of networks.

Invito a presentare proposte

H2020-SC1-BHC-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-SC1-2018-Single-Stage-RTD

Meccanismo di finanziamento

CSA - Coordination and support action

Coordinatore

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Contribution nette de l'UE
€ 865 235,00
Indirizzo
HEIDELBERGLAAN 100
3584 CX Utrecht
Paesi Bassi

Mostra sulla mappa

Regione
West-Nederland Utrecht Utrecht
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 865 235,00

Partecipanti (12)